Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy

MLA

Christianne Groeneveldt, et al. Preinduced Reovirus-Specific T-Cell Immunity Enhances the Anticancer Efficacy of Reovirus Therapy. Jan. 2022. EBSCOhost, https://doi.org/10.1136/jitc-2021-004464.

APA

Christianne Groeneveldt, Priscilla Kinderman, Jordi J C van Stigt Thans, Camilla Labrie, Lisa Griffioen, Marjolein Sluijter, Diana J M van den Wollenberg, Rob C Hoeben, Joke M M den Haan, Sjoerd H van der Burg, Thorbald van Hall, & Nadine van Montfoort. (2022). Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy. https://doi.org/10.1136/jitc-2021-004464

Chicago

Christianne Groeneveldt, Priscilla Kinderman, Jordi J C van Stigt Thans, Camilla Labrie, Lisa Griffioen, Marjolein Sluijter, Diana J M van den Wollenberg, et al. 2022. “Preinduced Reovirus-Specific T-Cell Immunity Enhances the Anticancer Efficacy of Reovirus Therapy,” January. doi:10.1136/jitc-2021-004464.